This COEP next earnings date page last updated 4/1/2026
COEP Next Earnings Date Notes
— Coeptis Therapeutics (ticker: COEP) is a clinical-stage biopharmaceutical company focused on developing innovative cell therapy platforms & treatments for patients with cancer and other serious diseases. The company's lead programs, including its SNAP-CAR technologies and CD38-GEAR, target key unmet needs in oncology & immunotherapy. For investors, it’s important to track pipeline progress & clinical trial milestones, especially as Coeptis aims to advance candidates into later-stage trials. Other crucial business metrics include the company's cash runway, R&D expenditures, and updates regarding partnerships or licensing agreements, all of which directly impact its ability to fund future growth. Keeping an eye on any reported safety and efficacy data will also be critical, as positive results can serve as catalysts for stock performance. During the upcoming earnings call, listen for management's commentary on trial timelines, regulatory interactions, and strategic priorities, since these will provide key signals about COEP's path to commercialization and long-term viability. The next projected earnings date for COEP is 5/13/2026 5:00 am (stay tuned for a confirmed earnings date once announced).
Coeptis Therapeutics Next Earnings Date FAQ
When is the COEP next earnings date?
I am following Coeptis Therapeutics, under stock symbol COEP, and I would like to know when is their next earnings date expected to be?
✔️Accepted answer:
The next projected earnings date for COEP is 5/13/2026 5:00 am (stay tuned for a confirmed earnings date once announced).
Suggested answer:
Are you looking to know which fiscal year and quarter will be reported at the next COEP earnings date? If so, it will be Q1 2026.
Suggested answer:
The COEP next earnings report will be compared against the prior year Q1 earnings of -1.110/share on 0.06M of revenue.
What stock exchange is COEP listed on?
I know the ticker symbol for Coeptis Therapeutics is COEP, but what stock exchange is COEP actually traded on?
✔️Accepted answer:
COEP is listed on NASDAQ
On this page we presented the
Coeptis Therapeutics Next Earnings Date information for Coeptis Therapeutics along with recent past earnings dates.
For Q4 of 2025, COEP reported earnings of -0.120/share, with the earnings report taking place on 3/19/2026. For Q3 of 2025, COEP reported earnings of -0.580/share, with the earnings report taking place on 11/14/2025. For Q2 of 2025, COEP reported earnings of -1.170/share, with the earnings report taking place on 8/14/2025. For Q1 of 2025, COEP reported earnings of -1.110/share, with the earnings report taking place on 5/14/2025. For Q4 of 2024, COEP reported earnings of -5.440/share, with the earnings report taking place on 3/28/2025. Based on these past earnings dates, the projected next earnings date for COEP is 5/13/2026 5:00 am.
Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining
a calendar of next earnings dates for each stock in their porfolio, such as Coeptis Therapeutics. When a company files its
10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three
hundred sixty five days! To say that earnings reports are important to Coeptis Therapeutics shareholders would
thus be an understatement! That's why we started the
NextEarningsDate.com website, to
make it easy for self directed investors to research Coeptis Therapeutics next earnings dates as well as any other stock out
there in our coverage universe, to see when the next COEP earnings date — or any other stock —
falls on the calendar. But we also present considerably more than just the next earnings date information alone,
so we encourage you to explore the additional pages linked above to look up COEP's past earnings as well, with
pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we
hope you'll think of our site the next time you need to learn about the
COEP next earnings date.